Exogenous melatonin is licensed to treat primary insomnia ... Participants will be randomised to receive either 2 mg slow release melatonin nightly, as Circadin or an identical placebo for 6 weeks, ...

DISCLAIMER: This site and the products offered are for entertainment purposes only, and there is no gambling offered on this site. This service is intended for adult audiences. No guarantees are made ...

The Annals of Pharmacotherapy. 2006;40(7):1327-1335. In overdose situations, modified-release delivery systems may continue to release their active ingredients; therefore, the management of an ...

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.